BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 7583678)

  • 1. Lipid peroxidation in brain: interactions of L-DOPA/dopamine with ascorbate and iron.
    Li CL; Werner P; Cohen G
    Neurodegeneration; 1995 Jun; 4(2):147-53. PubMed ID: 7583678
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Dopamine- and L-beta-3,4-dihydroxyphenylalanine hydrochloride (L-Dopa)-induced cytotoxicity towards catecholaminergic neuroblastoma SH-SY5Y cells. Effects of oxidative stress and antioxidative factors.
    Lai CT; Yu PH
    Biochem Pharmacol; 1997 Feb; 53(3):363-72. PubMed ID: 9065740
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Oxidative stress and the brain].
    Tanaka M
    Nihon Ronen Igakkai Zasshi; 1997 Sep; 34(9):706-10. PubMed ID: 9430979
    [TBL] [Abstract][Full Text] [Related]  

  • 4. l-DOPA administration enhances 6-hydroxydopamine generation.
    Maharaj H; Sukhdev Maharaj D; Scheepers M; Mokokong R; Daya S
    Brain Res; 2005 Nov; 1063(2):180-6. PubMed ID: 16257392
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Oxidative and non-oxidative mechanisms of neuronal cell death and apoptosis by L-3,4-dihydroxyphenylalanine (L-DOPA) and dopamine.
    Pedrosa R; Soares-da-Silva P
    Br J Pharmacol; 2002 Dec; 137(8):1305-13. PubMed ID: 12466240
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Iron-dependent cytotoxic effects of dopa on cultured neurons of the dorsal root ganglia].
    Tanaka M; Sotomatsu A; Kanai H; Hirai S
    Rinsho Shinkeigaku; 1990 Apr; 30(4):379-83. PubMed ID: 2117513
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of L-dopa, oxyferriscorbone and ferrous iron on in vivo lipid peroxidation.
    Dostert P; Benedetti MS; Frigerio E
    J Neural Transm Gen Sect; 1991; 84(1-2):119-28. PubMed ID: 2054143
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Involvement of reactive oxygen species generated from melanin synthesis pathway in phytotoxicty of L-DOPA.
    Hachinohe M; Matsumoto H
    J Chem Ecol; 2005 Feb; 31(2):237-46. PubMed ID: 15856781
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Analysis of 3-morpholinosydnonimine and sodium nitroprusside effects on dopamine release in the striatum of freely moving rats: role of nitric oxide, iron and ascorbic acid.
    Serra PA; Esposito G; Delogu MR; Migheli R; Rocchitta G; Grella G; Miele E; Miele M; Desole MS
    Br J Pharmacol; 2000 Oct; 131(4):836-42. PubMed ID: 11030735
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Iron-induced lipid peroxidation and inhibition of dopamine synthesis in striatum synaptosomes.
    Zaleska MM; Nagy K; Floyd RA
    Neurochem Res; 1989 Jul; 14(7):597-605. PubMed ID: 2550829
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Evaluation of the pro-oxidant and antioxidant actions of L-DOPA and dopamine in vitro: implications for Parkinson's disease.
    Spencer JP; Jenner A; Butler J; Aruoma OI; Dexter DT; Jenner P; Halliwell B
    Free Radic Res; 1996 Feb; 24(2):95-105. PubMed ID: 8845917
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Assessment of oxidative stress and activities of antioxidant enzymes depicts the negative systemic effect of iron-containing fertilizers and plant phenolic compounds in the desert locust.
    Renault D; Dorrah MA; Mohamed AA; Abdelfattah EA; Bassal TT
    Environ Sci Pollut Res Int; 2016 Nov; 23(21):21989-22000. PubMed ID: 27539469
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of oxidative stress induced by L-dopa on endogenous antioxidants in PC-12 cells.
    Vatassery GT; Smith WE; Quach HT
    Ann N Y Acad Sci; 2006 Aug; 1074():330-6. PubMed ID: 17105929
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A vitamin as neuromodulator: ascorbate release into the extracellular fluid of the brain regulates dopaminergic and glutamatergic transmission.
    Rebec GV; Pierce RC
    Prog Neurobiol; 1994 Aug; 43(6):537-65. PubMed ID: 7816935
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The possible role of iron in the etiopathology of Parkinson's disease.
    Youdim MB; Ben-Shachar D; Riederer P
    Mov Disord; 1993; 8(1):1-12. PubMed ID: 8419792
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Establishing the probable mechanism of L-DOPA in Alzheimer's disease management.
    Nivsarkar M; Banerjee A
    Acta Pol Pharm; 2009; 66(5):483-6. PubMed ID: 19894644
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Lipid peroxidation associated protein damage in rat brain crude synaptosomal fraction mediated by iron and ascorbate.
    Chakraborty H; Ray SN; Chakrabarti S
    Neurochem Int; 2001 Oct; 39(4):311-7. PubMed ID: 11551671
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Dopa and dopamine cause cultured neuronal death in the presence of iron.
    Tanaka M; Sotomatsu A; Kanai H; Hirai S
    J Neurol Sci; 1991 Feb; 101(2):198-203. PubMed ID: 1903438
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Plasma lipid peroxidation in sporadic Parkinson's disease. Role of the L-dopa.
    Agil A; Durán R; Barrero F; Morales B; Araúzo M; Alba F; Miranda MT; Prieto I; Ramírez M; Vives F
    J Neurol Sci; 2006 Jan; 240(1-2):31-6. PubMed ID: 16219327
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The effect of quinolinate on rat brain lipid peroxidation is dependent on iron.
    Stípek S; Stastný F; Pláteník J; Crkovská J; Zima T
    Neurochem Int; 1997 Feb; 30(2):233-7. PubMed ID: 9017671
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.